𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Furazolidone treatment of cutaneous leishmaniasis

✍ Scribed by J.M.L. Costa; R.N. Sampaio; M.S. Tada; E.A. Almeida; E.P. Veiga; A.V. Magalhães; P.D. Marsden

Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
103 KB
Volume
79
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transient effect of topical treatment of
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod
✍ Josef Seeberger; Saleh Daoud; Johannes Pammer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

## Abstract **Background** Treatment of cutaneous leishmaniasis can be painful and protracted and cosmetic results are often unsatisfying. The immune modulator imiquimod has been reported to be suitable for the treatment of a variety of infectious skin diseases and neoplasias. **Objective** We inv

Reactivation of cutaneous leishmaniasis
Reactivation of cutaneous leishmaniasis after surgery
✍ R.T. Czechowicz; T.P. Millard; H.R. Smith; R.E. Ashton; S.B. Lucas; R.J. Hay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Cutaneous leishmaniasis (CL) is caused by a parasite from the genus Leishmania. Infection is transmitted to humans from the bite of sandflies. We describe an 85-year-old man who developed CL on his face after recent cutaneous surgery in that site. The case is also unusual because the most likely sou